MoonLake Immunotherapeutics Class A MLTX
NASDAQ · United States · Health Technology
$11.57-0.13 (-1.11%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-10 | -0.84 | -0.92 | +8.5% | $0 | — | -9.1%$18.26→$16.59 |
| Q1 2026 | 2026-05-11 | -0.98 | -0.92 | -6.5% | — | — | +6.6%$17.06→$18.19 |
| Q4 2025 | 2026-02-25 | -0.92 | -0.94 | +2.1% | — | — | -2.9%$18.20→$17.68 |
| Q3 2025 | 2025-11-05 | -1.10 | -0.89 | -23.6% | — | — | +1.6%$10.13→$10.29 |
| Q2 2025 | 2025-08-05 | -0.87 | -0.76 | -14.5% | — | — | — |
| Q1 2025 | 2025-05-12 | -0.63 | -0.74 | +14.9% | — | — | — |
| Q4 2024 | 2025-02-26 | -0.72 | -0.59 | -22.0% | — | — | — |
| Q2 2024 | 2024-08-07 | -0.39 | -0.28 | -39.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.